Equipment has been designed and constructed to produce pharmaceutical microspheres in the microgravitational environment found aboard an orbiting U.S. Space Shuttle. The microcapsules in space (MIS) equipment will replace two space shuttle middeck storage lockers. Design changes have been incorporated into the MIS equipment reflecting the results of NASA mandated safety tests. MIS is tentatively manifested aboard the Space Shuttle Discovery on Mission STS-53 pending final safety certification by NASA. STS-53 is scheduled for launch on October 15, 1992. RA 2; Microencapsulation; Controlled-release; Space Shuttle; Antibiotics; Drug development.


    Access

    Access via TIB

    Check availability in my library


    Export, share and cite



    Title :

    Microencapsulation of Drugs in the Microgravity Environment of the United States Space Shuttle


    Contributors:
    T. R. Tice (author) / R. J. Holl (author)

    Publication date :

    1992


    Size :

    26 pages


    Type of media :

    Report


    Type of material :

    No indication


    Language :

    English





    Microgravity Environment of the Space Shuttle Columbia Middeck During STS-32

    B. J. Dunbar / D. A. Thomas / J. N. Schoess | NTIS | 1991


    The microgravity environment of the Space Shuttle Columbia middeck during STS-32

    Dunbar, Bonnie J. / Thomas, Donald A. / Schoess, Jeff N. | NTRS | 1991


    Microgravity Environment of the Space Shuttle Columbia Payload Bay During STS-32

    B. J. Dunbar / R. L. Giesecke / D. A. Thomas | NTIS | 1991


    Microgravity Forward Smolder Experiments in the Space Shuttle

    Bar-Ilan, A. / Rein, G. / Fernandez-Pello, A. C. et al. | British Library Conference Proceedings | 2003